Publications
155
Citations
952
Est. group size
~14
Recurring co-author estimate
Active years
8
Publishing since 2019
Erryk Katayama's publicly listed work spans two distinct areas: orthopaedic research on shoulder injury outcomes, and cancer biology research on how glucose metabolism affects pancreatic tumor response to immune-based treatments. The pancreatic cancer material appears to derive largely from a single detailed study examining how sugar availability influences the effectiveness of therapies targeting macrophages (immune cells that can either fight or help support tumors).
Publication output was low or absent before 2019, rose sharply starting in 2022, peaked in 2023-2024, and remains active into 2026, indicating a period of substantially increased research activity in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Elevated body mass index and clinical outcomes after surgical stabilization for shoulder instability: A systematic review
Journal of Orthopaedics · 2026
- Supplemental Figure 3 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Supplemental Figure 10 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Figure 2 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Figure 3 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Data from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Supplemental Figure 8 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Figure 1 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Supplemental Figure 11 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Supplemental Figure 6 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Supplemental Figure 4 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Supplemental Figure 1 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Supplemental Figure 12 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Figure 4 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Figure 6 from Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies
2026
- Annals of Surgical Oncology×25
- Journal of Gastrointestinal Surgery×17
- Surgery×9
- Journal of Surgical Oncology×6
- Journal of Orthopaedics×6
- Christian M. Schmidt
Medicine · Indiana University
- Christian M. Schmidt
Medicine · Indiana University
- Susan Tsai
Medicine · The Ohio State University
- Ahmad Hamad
Medicine · The Ohio State University
- Aayush Vishwanath
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile